DAPHNE Price

Overview

Welcome to Dwaey, specifically on DAPHNE Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Ethinylestradiol / Cyproterone acetate.
DAPHNE is available in the market in concentration 0.035mg, 2mg/Tablet and in the form of Tablets/Film-coated.

MITHRA PHARMACEUTICALS. N.V. is the producer of DAPHNE and it is imported from BELGIUM, The most popular alternatives of DAPHNE are listed downward .

Mode Of Action

A crystalline amino acid solution provides crystalline amino acids to promote protein synthesis and wound healing, and to reduce the rate of endogenous protein catabolism. Amino Acids , given by central venous infusion in combination with concentrated dextrose, electrolytes, vitamins, trace metals, and ancillary fat supplements, constitutes total parenteral nutrition (TPN). Amino Acids can also be administered by peripheral vein with dextrose and maintenance electrolytes.

Indication

• Protein supply for parenteral nutrition. Prophylaxis & therapy of protein deficiency resulting from increased protein losses &/or increased protein requirements.

Precaution

Hyperphenylalaninemia has been noted in severely ill, premature infants. In these patients, monitoring of the phenylalanine levels is recommended and the infusion rate adjusted as needed. Do not use if the solution is turbid or contains particles. Discard any unused portion.

Side Effects

• It is usually well tolerated. Yet nausea
• vomiting
• flushing and sweating have been observed during infusion of amino acid IV at rates exceeding the recommended maximal rate. Hypersensitivity reactions have been reported. Like all hypertonic infusion solution
• thrombophlebitis may occur when peripheral veins are used. The incidence may be reduced by the simultaneous infusion of 10% fat emulsion. If it is infused to severely ill patients
• premature infants
• hyperphenylalaninemia may occur.

Contra indication

Contraindicated in patients with inborn errors of amino acids metabolism. Moreover, amino acid should not be used in patients with hepatic coma or metabolic disorders involving impaired nitrogen utilization.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks